scholarly journals Adult Patients with Respiratory Distress: Current Evidence-based Recommendations for Prehospital Care

2020 ◽  
Vol 21 (4) ◽  
Author(s):  
Sammy Hodroge ◽  
Melody Glenn ◽  
Amelia Breyre ◽  
Bennett Lee ◽  
Nick Aldridge ◽  
...  
2020 ◽  
Vol 40 (5) ◽  
pp. 15-24
Author(s):  
Rachel E. Smith ◽  
Megan M. Shifrin

Topic Acute respiratory distress syndrome is a complex respiratory disease that can be induced by influenza virus infection. Critical care providers are uniquely positioned to manage this pathological progression in adult patients through evidence-based practice. Clinical Relevance Influenza and subsequent acute respiratory distress syndrome are associated with extremely high morbidity and mortality in adult patients in the United States. Although evidence-based medical management strategies can alter the clinical trajectory of acute respiratory distress syndrome and improve outcomes, critical care providers do not always implement these measures. Purpose To provide critical care providers with an overview of the pathological progression of influenza-induced acute respiratory distress syndrome and the current evidence-based strategies for management. Content Covered This article reviews the epidemiology and pathophysiology associated with influenza-induced acute respiratory distress syndrome, the criteria for diagnosis, and the evidence-based medical management.


2018 ◽  
Vol 19 (3) ◽  
pp. 527-541 ◽  
Author(s):  
Ashley Sanello ◽  
Marianne Gausche-Hill ◽  
William Mulkerin ◽  
Karl Sporer ◽  
John Brown ◽  
...  

2016 ◽  
Vol 17 (2) ◽  
pp. 104-128 ◽  
Author(s):  
Nancy Glober ◽  
Karl Sporer ◽  
Kama Guluma ◽  
John Serra ◽  
Joe Barger ◽  
...  

2017 ◽  
Vol 18 (3) ◽  
pp. 419-436 ◽  
Author(s):  
Eric C. Silverman ◽  
Karl A. Sporer ◽  
Justin M. Lemieux ◽  
John F. Brown ◽  
Kristi L. Koenig ◽  
...  

2015 ◽  
Vol 16 (7) ◽  
pp. 983-995 ◽  
Author(s):  
P. Savino ◽  
Karl Sporer ◽  
Joe Barger ◽  
John Brown ◽  
Gregory Gilbert ◽  
...  

2020 ◽  
Vol 17 (3) ◽  
pp. 318-324 ◽  
Author(s):  
Khadije Saket ◽  
Jalil T. Afshari ◽  
Ehsan Saburi ◽  
Mahdi Yousefi ◽  
Roshanak Salari

From ancient times, medicinal plants have been usually utilized to treat many disorders, but today, interest in these herbs is again aroused, because of their fewer side effects and low-cost. In traditional medicine, for many diseases, various medicinal herbs have been suggested so far. Drimia maritime, also named squill, is an important medicinal plant for the treatment of many diseases, especially respiratory diseases. In the current evidence-based study, we conducted a review of the general characteristics, ingredients, administration form, and side effects of squill in traditional medicine. For this purpose, traditional Persian medicine literatures and electronic databases were examined including PubMed, Scopus, and Google Scholar. Many compounds are isolated from D.maritima, including scillaren, scillirubroside, scillarenin, and bufadienolide glycosides. Oxymel is the most commonly used form of squill for various diseases, especially respiratory diseases. Besides, squill has been used in the treatment of cardiovascular, digestive, and dermatological disorders, it is also used against various cancer cells for its antioxidant and cytotoxic properties. Moreover, there is relatively reliable evidence of its benefits for bacterial and helminthic infections, rheumatism, edema, gout, abortion induction, healing of wounds and urine induction. It seems that supplementary studies are required to explore the bioactive agents and their effective mechanisms.


Sign in / Sign up

Export Citation Format

Share Document